secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001628280-26-011630
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health Q4 net loss $189M, revenue $1.57B; 2026 guidance Adj EBITDA breakeven
--------------------------------------------------------------------------------

- Q4 net loss $189M vs $106M loss YoY; FY net loss $391M vs $260M loss.
- Medical margin Q4 negative $74M vs positive $1M YoY; FY negative $57M vs positive $205M.
- Adjusted EBITDA Q4 loss $142M vs $84M; FY loss $296M vs $154M.
- Membership 625k (-5% YoY) from market exits; MA members 511k, ACO 114k.
- 2026 guidance: revenue $5.41-5.58B, Adj EBITDA ($15M)-$15M midpoint breakeven.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828026011630/0001628280-26-011630-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828026011630/agl-20260225.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-011630

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer